Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Sequent Scientific Limited ( (IN:SEQUENT) ).
Sequent Scientific Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2025, during a board meeting. The results, reviewed by independent auditors, indicate the company’s continued financial performance and compliance with regulatory standards, potentially impacting its operational strategies and stakeholder interests positively.
More about Sequent Scientific Limited
Sequent Scientific Limited operates in the life sciences industry, focusing on the development and production of pharmaceutical products. The company is involved in providing a range of services and products related to pharmaceuticals, with a market focus on enhancing its position in the life sciences sector.
Average Trading Volume: 87,454
Technical Sentiment Signal: Buy
Current Market Cap: 59.94B INR
For a thorough assessment of SEQUENT stock, go to TipRanks’ Stock Analysis page.